학술논문
Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial.
Document Type
Editorial & Opinion
Author
Burkhardt G; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany. Electronic address: gerrit.burkhardt@med.uni-muenchen.de.; Goerigk S; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany; Department of Psychology, Charlotte Fresenius Hochschule, Munich, Germany.; Bulubas L; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Dechantsreiter E; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Keeser D; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Kumpf U; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Soldini A; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Wolf J; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Amann BL; Mental Health Institute Hospital del Mar, Barcelona, Spain; Centre Fòrum Hospital del Mar Research Institute, Barcelona, Spain; Pompeu Fabra University Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto Carlos III, Madrid, Spain.; Plewnia C; Tübingen Center for Mental Health, Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.; Fallgatter A; Tübingen Center for Mental Health, Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.; Langguth B; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.; Normann C; Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany; Center for Basics in Neuromodulation (NeuroModulBasics), University of Freiburg, Freiburg, Germany.; Frase L; Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Freiburg, Germany; Department of Psychosomatic Medicine and Psychotherapy, Medical Center, University of Freiburg - Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Zwanzger P; kbo-Inn-Salzach-Klinikum, Clinical Center for Psychiatry, Psychotherapy, Psychosomatic Medicine, Geriatrics and Neurology, Gabersee, Wasserburg/Inn, Germany.; Kammer T; Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.; Schönfeldt-Lecuona C; Department of Psychiatry and Psychotherapy III, University of Ulm, Ulm, Germany.; Kamp D; Department of Psychiatry and Psychotherapy, LVR-Klinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Medical Faculty, Düsseldorf, Germany.; Bajbouj M; Department of Psychiatry and Psychotherapy, Charité-Campus Benjamin Franklin, Berlin, Germany.; Falkai P; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Brunoni AR; Departments of Internal Medicine and Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.; Bertsch K; Department of Psychology, Ludwig-Maximilians-University Munich, Munich, Germany.; Jobst A; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Reinhard MA; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.; Padberg F; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
Source
Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Ireland NLM ID: 7911385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7123 (Electronic) Linking ISSN: 01651781 NLM ISO Abbreviation: Psychiatry Res Subsets: MEDLINE
Subject
Language
English
Abstract
Competing Interests: Declaration of Competing Interest FP has received grants from the German Research Foundation (DFG; grant number: BR 4264/6-1) and the German Federal Ministry of Education and Research (BMBF; grant number: 01EW1903); consulting fees from Brainsway Inc. (Jerusalem, Israel) as a member of the European Scientific Advisory Board and from Sooma (Helsinki, Finland) as a member of the International Scientific Advisory Board; honoraria for workshops from Mag&More GmbH (Munich, Germany); and honoraria for lectures from neuroCare Group (Munich, Germany) and Brainsway Inc. (Jerusalem, Israel); and has received equipment from Mag&More GmbH (Munich, Germany), neuroCare Group (Munich, Germany), and Brainsway Inc. (Jerusalem, Israel). BL received honoraria for consultancy and speakers’ fees from ANM, AstraZeneca, Autifony Therapeutics, Decibel Therapeutics, Desyncra, Gerson Lehmanns Group, Lundbeck, Merz, MagVenture, Medical Tribune, Neurolite, Neuromod, Novartis, Pfizer, Rovi, Schwabe, Sea Pharma, Servier, Sonova and Sound Therapeutics; research funding from the Tinnitus Research Initiative, Bayhost, the German Research Foundation, the German Federal Ministry of Education and Research, the American Tinnitus Association, AstraZeneca, cerbomed, Neuromod and the European Union; and has received equipment from MagVenture and Deymed Diagnostic. PF has received research support/honoraria for lectures or advisory activities from Boehringeer-Ingelheim, Janssen, Lundbeck, Otsuka, Recordati, and Richter. CP is a managing partner of PsyKit GmbH, Tübingen, Germany. GB, SG, LB, ED, DKe, UK, AS, JW, BA, AF, CN, LF, PZ, TK, CSL, DKa, MB, AB, KB, AJ, and MR declare no competing interests.